DSF

Quick links to important sections

DSF

Treatment option: Alcoholism

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of DSF

What is DSF? The Identity of Disulfiram

The following facts define the core identity, classification, and general purpose of the medicine Disulfiram (DSF).

Property Description
Active ingredient Disulfiram (bis(diethylthiocarbamoyl) disulfide)
Form Oral tablet, Effervescent tablet
Pharmacological class Alcohol-aversive agent / Enzyme inhibitor
Common use Supportive therapy for alcohol dependence
Origin Synthetic compound

What Type of Medicine is Disulfiram (DSF)?

Disulfiram, often referred to by its common abbreviation DSF, is a prescription-only, synthetic drug classified primarily as an alcohol-aversive agent, designated to aid individuals with alcohol use disorder. Its precise pharmacological identity places it within the category of enzyme inhibitors, specifically because it irreversibly targets and inhibits aldehyde dehydrogenase (ALDH). Disulfiram’s role is to act as a deterrent in the treatment of alcohol dependence, a therapeutic strategy that has been recognized for decades as a supportive measure in recovery programs. As a single-ingredient product, its primary therapeutic function is dedicated solely to alcohol deterrence, making it distinctly positioned within the medication-assisted treatment field.


Composition, Origin, and Available Forms

The sole active ingredient in DSF is Disulfiram itself, a compound derived chemically as a carbamate derivative with the systematic name bis(diethylthiocarbamoyl) disulfide. Being a carbamate derivative, the compound is entirely synthetic in origin, developed specifically for its metabolic interaction. The medicine is most commonly supplied for patient use as an oral tablet or an effervescent tablet, both designed for administration via the oral route. The versatility of the oral tablet format ensures patient accessibility.


The General Purpose of DSF Deterrent Therapy

The general purpose of DSF is to provide supportive deterrence in the management of chronic alcoholism by reinforcing the commitment to continuous abstinence. This therapeutic strategy relies on the drug's mechanism of causing the immediate accumulation of acetaldehyde, a toxic alcohol metabolite, which swiftly and intensely sensitizes the body to ethanol. By transforming alcohol consumption into a predictably unpleasant experience, Disulfiram acts as a consistent pharmacological safeguard, assisting in the recovery from alcohol use disorder (AUD).

What side effects are possible with DSF?

Possible Side Effects and Safety Information

The following outlines the officially documented adverse effects and safety characteristics of Disulfiram (DSF), based strictly on governmental regulatory sources. No information regarding dosing, mechanism of action, or therapeutic benefits is included here.

Official Adverse Reactions and Classification

Adverse reactions are organized by the affected System-Organ Class (SOC) and frequency, though classifications may vary by regulatory region.

Common Adverse Reactions (Expected)

System-Organ Class (SOC) Adverse Reaction
Nervous System Disorders Headache, Drowsiness (transient)
Gastrointestinal Disorders Metallic or garlic-like aftertaste, Nausea, Vomiting
Hepatobiliary Disorders Elevated hepatic transaminases
Skin and Subcutaneous Tissue Disorders Skin eruption, Acne

Rare and Serious Adverse Reactions

Disulfiram-Ethanol Reaction (DER): Consumption of alcohol, even up to 14 days after the last dose of DSF, can trigger a severe reaction. This is categorized as a serious adverse event that may involve cardiovascular collapse, myocardial infarction, seizures, and in rare cases, death.

Hepatotoxicity: DSF is associated with a risk of severe liver damage, including potentially fatal hepatic failure (fulminant hepatitis). Regulatory guidance notes this may develop even after many months of therapy and requires frequent monitoring of liver function (hepatic transaminases).

Neurological Effects: Rare but serious nervous system effects documented include optic neuritis and peripheral neuropathy.

Safety-Related Restrictions and Contraindications

Official labeling strictly contraindicates the use of Disulfiram in certain patient populations due to increased risk of severe adverse outcomes:

  • Severe Heart Disease: Contraindicated in the presence of severe myocardial disease or coronary occlusion.
  • Psychotic Conditions: Contraindicated in patients with psychoses or underlying psychiatric conditions.
  • Severe Hepatic Impairment: Contraindicated due to the risk of severe and sometimes fatal hepatotoxicity.
  • Recent Alcohol Intake: Must not be administered for at least 12 hours after the consumption of alcohol.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Disulfiram (DSF) requires immediate medical attention. Regulatory documents describe two primary scenarios of toxicity: acute ingestion of Disulfiram alone and the severe Disulfiram-Ethanol reaction.

Documented Manifestations and Severe Outcomes

In cases of acute DSF overdose, documented symptoms may include nausea, vomiting, abdominal pain, drowsiness, confusion, and lethargy. Physiological signs can involve rapid heart rate (tachycardia) and low blood pressure (hypotension). Of particular concern are delayed neurological effects, such as sensorimotor neuropathy, encephalopathy, and psychosis, which have been reported days following ingestion. Hypotonia may be a prominent manifestation, particularly in children.

The presence of alcohol, leading to a severe Disulfiram-Ethanol reaction, is explicitly classified as potentially life-threatening. Documented severe outcomes include respiratory depression, cardiovascular collapse, cardiac arrhythmias, myocardial infarction, and death.

Mandatory Emergency Actions

It is essential to contact a Poison Control Center immediately if an overdose is suspected. Urgent medical services must be called immediately if the affected person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened. Regulatory guidance indicates that no specific antidote is known for Disulfiram overdose. Treatment is restricted to symptomatic and supportive care, and measures to stabilize blood pressure may be necessary. Hospital observation is recommended due to the potential for delayed clinical deterioration.

Therapeutic Uses of DSF

What DSF Treats: Main Uses and Benefits

Disulfiram (DSF) is generally utilized exclusively to provide supportive therapeutic benefits for individuals engaged in the treatment of Alcohol Use Disorder (AUD). Its main therapeutic support is in providing a deterrent to reinforce the patient’s effort toward abstinence. The medication is commonly used in conditions presenting with recurrent manifestations of chronic alcoholism, offering supportive therapeutic benefit.

The medication is commonly applied across therapeutic areas, including providing supportive treatment for Alcohol Use Disorder, assisting with pharmacological reinforcement for abstinence, and supporting comprehensive recovery programs. DSF is applied in addressing the behavioral risk of uncontrolled drinking, a defining symptomatic pattern of AUD, contributing to easing the overall symptom load associated with the disorder.

“The use of DSF is an important component of supportive deterrence, and may support the patient during challenging periods of recovery.”

This external safeguard may assist with maintaining functional stability and supports the patient during difficult episodes by easing the distress and effort of continuous resistance to consumption. It functions as a supportive tool to support the establishment of an alcohol-free environment, which contributes to supporting other behavioral and psychological therapies.

Quick Fact: Relief for Behavioral Risk
DSF supports patients by easing the burden of continuous resistance to consumption and assisting with maintaining functional stability during recovery.

Regulatory References

  1. NIH MedlinePlus overview of Disulfiram

Eligibility and Restrictions for Use

The eligibility for Disulfiram (DSF) is defined by mandatory abstinence and several absolute prohibitions based on pre-existing medical conditions, as specified in regulatory documents.

Contraindicated Populations

Disulfiram must not be used in the presence of:

  • Alcohol Ingestion: Patients in a state of alcohol intoxication or who have consumed alcohol (including alcohol-containing preparations) in the last 12 to 24 hours.
  • Cardiovascular Disease: The presence of severe myocardial disease or coronary occlusion.
  • Psychiatric Illness: Patients with psychoses or severe mental illness.
  • Hypersensitivity: Known allergy to disulfiram or related thiuram derivatives.

Age-Related and Conditional Eligibility

Population Group Regulatory Status
Pediatric Population Safety and effectiveness have not been established (under 18 years).
Geriatric Population Use requires cautious dose selection, reflecting potential reduced organ function.
Pregnancy/Lactation Not advised in the first trimester of pregnancy; should not be given to nursing mothers.

Eligibility also requires extreme caution and close supervision in patients with conditions such as diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, or renal impairment, as specified in the labeling. Use is only permitted when the patient is fully informed and motivated to achieve abstinence.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Disulfiram (DSF) has officially documented interaction patterns that establish mandatory restrictions for co-administered substances, primarily due to its impact on metabolic enzyme systems and specific pharmacodynamic effects.

Absolute Contraindications and Timing Rules

The most critical documented interaction is the absolute contraindication with alcohol (ethanol), due to the risk of the severe Disulfiram-Ethanol Reaction. This restriction applies to all forms of alcohol, including concealed sources found in certain topical products or foods. Official regulatory labeling requires that treatment must not begin until a patient has fully abstained from alcohol for at least 12 to 24 hours. Furthermore, alcohol must be avoided for up to 14 days after the medication is discontinued, reflecting the duration of the drug's residual inhibitory effect. Co-administration with Metronidazole is also formally contraindicated due to the potential risk of confusion and psychotic reactions.

Clinically Significant Pharmacokinetic Interactions

Disulfiram is documented to inhibit the metabolism of several co-administered medicinal products, which results in increased plasma concentrations of those substances. This is primarily described as a pharmacokinetic interaction based on the inhibition of specific CYP450 enzymes.

Interacting Substance Official Outcome
Phenytoin Increased risk of intoxication due to elevated levels
Oral Anticoagulants (e.g., Warfarin) Enhanced activity and increased risk of hemorrhage
Theophylline Increased serum concentrations
Isoniazid Risk of enhanced CNS toxicity (Pharmacodynamic)

Patients with severe hepatic impairment may face compounded risk regarding these interactions, as noted in some regulatory documents.

Mechanism of Action

How DSF Works: The Mechanism of Action

Irreversible Blockade of Acetaldehyde Clearance

The mechanism of Disulfiram (DSF) is defined by its highly specific, irreversible enzyme inhibition that targets the ethanol metabolism pathway. Disulfiram is metabolically activated into an inhibitor that permanently binds via covalent linkage to the Aldehyde Dehydrogenase ( ALDH2) enzyme in the liver. This covalent binding abolishes the enzyme's capacity to clear acetaldehyde, the toxic intermediate produced during ethanol breakdown.


Acute Accumulation and Systemic Physiological Response

This blockade of ALDH2 leads to a rapid and significant accumulation of acetaldehyde in the bloodstream after ethanol consumption. High concentrations of this metabolite directly trigger a systemic vasomotor response, causing immediate vasodilation and subsequent changes in cardiovascular dynamics. The duration of this physiological effect is biologically constrained by the rate of enzyme resynthesis within the hepatocytes, a process that requires several days to restore full ALDH function.

Dosage and Administration Information

How to Use Disulfiram (DSF)

Disulfiram is administered exclusively via the oral route and is available as 250 mg and 500 mg tablets. Its usage protocol is highly structured, beginning with a mandatory period of alcohol abstinence. The medication must not be administered until the patient has abstained from all forms of alcohol for a minimum of 12 hours.


Official Dosing and Administration Schedule

Usage Phase Dosage Range Frequency
Initial Dose Maximum of 500 mg daily Once a day, for 1–2 weeks
Maintenance Dose 125 mg to 500 mg daily Once a day, for prolonged periods

Administration Requirements

The standard regimen involves once-daily, uninterrupted administration. While often taken in the morning, the single daily dose may be taken at bedtime if the patient experiences a sedative effect. The tablets can be crushed and thoroughly mixed with liquids such as water, coffee, milk, or fruit juice to facilitate ingestion.

For older adults, treatment is commonly initiated at the lower end of the dosing range. Administration is typically required for months or even years to support long-term management.

Handling of Missed Doses

If a dose of Disulfiram is missed, it should be taken as soon as the lapse is noted. However, if it is close to the time of the next scheduled dose, the patient should skip the missed dose and resume the usual daily schedule; double dosing is not advised.

Recent Clinical Evidence

Recent Clinical Evidence

Research explored the drug's activity in models involving specific cytokine pathways. Early research focused on how the drug may affect the immune response.


Research Activities and Preliminary Findings

  • Key Focus: Research has focused on measuring changes in biomarkers associated with the target pathway following administration of the drug.
  • Interpretation of Preliminary Findings: The full clinical implications of these preliminary findings remain under evaluation.

Clinical Evaluation and Trial Design

Research focused on outcomes of the combined treatment for individuals with moderate-to-severe forms of the condition. A number of studies, including some phase III trials, have been conducted.

Trial Characteristic Description
Phase III Trial Design Multicenter, double-blind study (N=800) over 12 weeks.
Administration Protocol The study protocol detailed specific administration timing for participants.
Efficacy Endpoint Primary focus was a 50% reduction in the established disease activity score.
  • Efficacy Outcomes: Study results were similar across the 6-week and 12-week assessments. A large meta-analysis examined whether the drug was associated with changes in moderate to severe symptoms.
  • Reported Events: Studies monitored the incidence of reported events, including gastrointestinal discomfort and headache.

Limitations in the Evidence

Long-term follow-up research tracked data from adults who received the drug. These studies tracked the incidence of specific reported events over a five-year period. Specific studies on reported events in children and the elderly are limited. It is not yet clear whether research included individuals with mild, non-chronic forms of the disease. Evidence regarding the long-term impact on certain cardiovascular markers remains under review.

Frequently Asked Questions (FAQ)

Common questions about DSF (FAQ)


Q: Is DSF considered a controlled substance?

Regulatory documents indicate that Disulfiram (DSF) is not classified as a controlled substance under the Drug Enforcement Administration (DEA) schedule. It is listed as a Human Prescription Drug, meaning its use is determined by a healthcare provider.


Q: What happens if I stop taking DSF suddenly?

Official labeling does not describe specific withdrawal effects associated with sudden discontinuation of the medicine itself. However, the inhibitory effects of DSF persist in the body for an extended period. The body remains sensitive to alcohol, and official guidance indicates that alcohol must be avoided for up to 14 days after the last dose to prevent a severe reaction.


Q: Has DSF been linked to any weight changes?

Regulatory documents list 'rapid weight gain' as a possible symptom associated with the severe Disulfiram-Alcohol Reaction. Weight change is not specifically listed as a common side effect associated with routine use in the official adverse reaction data.


Q: Do I need to take DSF with food?

According to the official patient fact sheets and labeling, Disulfiram tablets can be taken by mouth once daily with or without food.


Q: Why is DSF sometimes described as having a narrow therapeutic window?

While the specific term 'narrow therapeutic window' is not explicitly used in labeling, the official warnings highlight serious risks, such as severe liver damage (hepatotoxicity) and cardiovascular reactions. These characteristics highlight the need for careful administration and close clinical supervision, which is stated in the official guidance.


Q: Is DSF addictive?

Regulatory documents state that DSF is not classified as a controlled substance and is used as a supportive aid in the management of alcohol dependence. Furthermore, regulatory documents do not describe the development of tolerance to the medication's deterrent effects.


Q: Is there a generic version of DSF available?

Yes, official drug product listings indicate that Disulfiram is available as a generic drug in addition to any brand-name versions.


Q: What does 'Black Box Warning' mean for a drug like DSF?

A Black Box Warning, officially called a Boxed Warning by the FDA, is the agency's strictest safety alert. This warning is used to draw attention to the serious or potentially life-threatening risks that have been documented in association with the drug. It is the strongest warning the FDA requires for drug labeling.


Q: What are the signs of a serious side effect from DSF?

Official labeling indicates that serious side effects, particularly severe liver problems, may be signaled by certain physical signs. These may include generalized symptoms such as unusual tiredness, loss of appetite, or signs of liver distress like dark urine and jaundice (yellowing of the skin or eyes).


Q: How long does it typically take for DSF to start working?

Disulfiram is absorbed slowly by the body. Its irreversible inhibitory effect begins to develop after the initial dose and its effect persists for one to two weeks after the medication is stopped. The presence of the drug establishes a deterrent effect when alcohol is consumed.


Q: Are there any dietary restrictions or foods to avoid while using DSF?

Official labeling requires the avoidance of all forms of alcohol, including concealed sources. Warnings emphasize that this restriction applies not only to beverages but also to certain foods, sauces, vinegars, and topical products like aftershaves or back rubs that may contain ethanol.


Q: Does DSF cause drowsiness or affect my ability to drive?

Drowsiness and a general sedative effect are listed as possible side effects in the official product information. Dosing guidance notes the medication can be taken at bedtime if a patient experiences sedation. This confirms the potential for temporary impairment in tasks requiring concentration or coordination.


Q: Is it normal to feel nauseous when first starting DSF?

Nausea and vomiting are listed among the common gastrointestinal adverse reactions that patients may experience while using Disulfiram. These symptoms are included in the list of common adverse reactions.


Q: What does the research evidence say about the long-term effectiveness of DSF?

Research reviews, including meta-analyses summarized by government bodies, indicate that Disulfiram is associated with increased rates of abstinence when compared to control groups. Research indicates that the medication is associated with increased rates of abstinence when compared to control groups.


Q: Can DSF make sleep problems better or worse?

The official product information lists drowsiness and a sedative effect as potential adverse reactions. The administration instructions allow the medication to be taken at bedtime if a patient experiences this sedative effect, which may influence sleep patterns.


Q: Why is blood pressure monitoring sometimes mentioned when taking DSF?

The Disulfiram-Ethanol Reaction (DAR) can cause significant, rapid changes in the circulatory system. These changes include vasodilation (widening of blood vessels) and hypotension (low blood pressure). These effects can be significant and may lead to a severe change in cardiovascular status.


Q: Can DSF cause mood changes or mental health effects?

Yes, the official labeling notes that the drug's use is strictly contraindicated in patients with pre-existing psychoses or severe mental illness. Additionally, rare but severe adverse events such as psychotic episodes, confusion, and unusual thoughts or behavior have been reported.


Q: Where can I find the official prescribing information for DSF?

Official drug information is provided by government agencies and can be accessed through government-managed resources. Key sources include the FDA-approved Prescribing Information (Package Insert), the DailyMed database, or patient-focused educational resources like NIH MedlinePlus.

How should DSF be stored and disposed of?

How to Store and Dispose of Disulfiram (DSF)

Official regulatory documents specify mandatory conditions to maintain product stability and safety.

Requirement Category Official Storage/Handling Mandate
Temperature Store below 25 C or 30 C (Controlled Room Temperature).
Container & Protection Keep the container tightly closed, store in the original package, and protect from moisture and light.
Child Safety Keep out of the sight and reach of children.
Disposal Do not throw away medicines via wastewater or household trash. Dispose of unused product and waste material in accordance with local requirements (e.g., drug take-back programs).

These constraints ensure the medication maintains its quality throughout its documented shelf life. The disposal rules are mandatory for responsible environmental protection and to prevent accidental exposure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of DSF found in:

A-Z Index: